FIGURE 2.
Kaplan-Meier estimates of 5-year relapse-free survival of the sacrococcygeal yolk sac tumor by pathologic response to neoadjuvant chemotherapy. The 5-year relapse-free survival rate of group good response (n=9) was significantly higher than that of group poor response (n=11) (P=0.026).